Wang Melinda, Jutras Gabrielle, Cullaro Giuseppe, Dhruva Anand, Lai Jennifer C
Department of Internal Medicine, University of California San Francisco, San Francisco, CA 94143, United States.
Division of Hepatology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal H2X 0A9, Quebec, Canada.
World J Hepatol. 2025 Mar 27;17(3):103537. doi: 10.4254/wjh.v17.i3.103537.
Dietary supplement (DS) usage among United States adults has significantly increased. Patients with steatotic liver disease (SLD) may have unique motivations to take DS in light of their liver condition and co-morbidities.
To characterize DS use in SLD patients and explore motivations for their use.
Adults ≥ 18 years old with complete transient elastography and dietary data from the National Health and Nutrition Examination Survey between January 2017 and March 2020 were studied. SLD was defined using consensus criteria, combining clinical indicators with elastography thresholds. The DS Questionnaire (DSQ) was used to record participants' use of DSQ. Sample weights were applied to estimate national prevalence.
Of 2413 participants with SLD, 1058 reported using DS, for an estimated prevalence of 44.8% [standard error (SE) 2.4] with an average of 2.6 (SE 0.2) DS per person. Among SLD participants taking DSQ, 53.2% (SE 3.3) reported using non-vitamin/non-mineral ones, with an average of 1.8 (SE 0.1) such supplements per person. DS users were more likely to be female, have higher levels of education, and have greater food security (P < 0.02 for all). The most common motivations for using DS were to follow doctor's advice (36.7%, SE 1.8), to improve overall health (22.1%, SE 2.0), and to maintain health (19.2%, SE 1.9).
Nearly half of individuals with SLD report taking DS. This study underscores the pressing need to deepen our understanding of DS use/motivations to develop tailored patient counseling strategies.
美国成年人使用膳食补充剂(DS)的情况显著增加。鉴于脂肪性肝病(SLD)患者的肝脏状况和合并症,他们可能有服用DS的独特动机。
描述SLD患者使用DS的情况,并探究其使用动机。
对2017年1月至2020年3月期间参加美国国家健康与营养检查调查、有完整瞬时弹性成像和饮食数据的18岁及以上成年人进行研究。使用共识标准,结合临床指标和弹性成像阈值来定义SLD。采用DS问卷(DSQ)记录参与者使用DS的情况。应用样本权重来估计全国患病率。
在2413名SLD参与者中,1058人报告使用DS,估计患病率为44.8%[标准误(SE)2.4],每人平均使用2.6种(SE 0.2)DS。在服用DSQ的SLD参与者中,53.2%(SE 3.3)报告使用非维生素/非矿物质DS,每人平均使用1.8种(SE 0.1)此类补充剂。DS使用者更可能为女性、受教育程度较高且粮食安全状况较好(所有P值均<0.02)。使用DS最常见的动机是听从医生建议(36.7%,SE 1.8)、改善整体健康(22.1%,SE 2.0)和维持健康(19.2%,SE 1.9)。
近一半的SLD患者报告服用DS。本研究强调迫切需要加深我们对DS使用情况/动机的理解,以制定针对性的患者咨询策略。